Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease

Circulation

Volumn 97, Issue 7, 1998, Pages 645-650

  Schumacher, B ^a   Peecher, P ^b   Von Specht, B U ^b   Stegmann, Th ^b  

^a Klinikum Fluda   (Germany)

^b NONE

Author keywords

Angiogenesis; Coronary disease; Growth substances

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; GROWTH FACTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHORIOALLANTOIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032562232     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.7.645     Document Type: Article

References (29)

1. Kirklin JW, subcommittee and Task Force Members. Guidelines and indications for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol. 1991;17:543-589.
2. Lytle BW, Loop FD, Cosgrove DM, Ealsey K, Taylor PC. Long-term (five to twelve years) serial studies of internal mammary artery and saphenous vein coronary bypass graft. J Thorac. Cardiovasc Surg. 1985;89:248-258.
3. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181-191.
4. Fasol R, Schumacher B, Schlaudraff K, Hauenstein KH, Seitelberger R. Experimental use of a modified fibrin-glue to induce site-directed angiogenesis from the aorta to the heart. J Thorac Cardiovasc Surg. 1994;107:1432-1439.
5. Schlaudraff K, Schumacher B, Seitelberger R, v. Specht B-U, Schlosser V, Fasol R. An experimental study of in situ and in vivo growth of new arteries by the angiogenetic growth factor HBGF-I. Thorac Cardiovasc Surg 1992;40:136.
6. Schlaudraff K, Schumacher B, Seitelberger R, von Specht B-U, Schosser V, Fasol R. Can you grow new arteries for CV surgeons? J Cardiovasc Surg. 1992;33:47.
7. Schlaudraff K, Schumacher B, von Specht B-U, Seitelberger R, Schlosser V, Fasol R. Growth of new coronary vascular structures by angiogenetic growth factors Eur J Cardiothorac Surg. 1993;7:637-644.
8. Thompson JA, Anderson KD, Di Pietro JM, Zwiebel JA, Zametta M, Anderson WF, Maciag T. Site-directed neovessel formation in vivo. Science. 1988;241:1349-1352.
9. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuryama M, Kurashima C, Ito H. Salvage of infarcted by angiogenic action of basic fibroblast growth factor. Sciecne. 1992;257:1401-1402.
10. Dionne CA, Crumley G, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, Schlessinger J. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J. 1990;9:2685-2692.
11. Friesel R, Burgess WH, Mehrman T, Maciag T. The characterization of the receptor for endothelial cell growth factor by covalent ligand attachment. J Biol Chem. 1986;261:7581-7584.
12. Gimenez-Gallego G, Rodkey J, Bennett C, Rios-Candelore M, DiSalvo J. Thomas K. Brain-derived acidic fibroblast growth factor: complete amino acid sequence and homologies. Science. 1985;230:1385-1388.
13. Jaye M, Howk R, Burgess W. Ricca G, Chiu IM, Ravera M, O'Brien S, Modi W, Macoag T, Drohan W. Human endothelial cell growth factor: cloning, nucleotide sequence and chromosome localisation. Science. 1986;233:541-545.
14. Forough R, Engleka K, Thompson JA, Jackson A, Imamura T, Maciag T. Differential expression in Escherichia coli of the alpha and beta forms of heparin-binding acidic fibroblast growth factor 1: potential role of RNA secondary structure. Biochem Biophys Acta. 1991;1090:293-298.
15. Laemmli SJR, Clevage of structural proteins during assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
16. Bjerrum OJ, Heegaard NHH, eds. Handbook of Immunoblotting of Proteins, Volume I: Technical Descriptions. Boca Raton, Fla: CRC Press: 1988.
17. Gospodarowicz D, Cheng J, Lui GM, Baird A, Böhlent P. Isolation of brain fibroblast growth factor by heparin-sepharose affinity chromatography: identity with pituitary fibroblast growth factor. Proc Natl Acad Sci U S A. 1984;81:6963-6967.
18. Auerbach R, Kabail L, Knighton D, Folkman J. A simple procedure for the long-term cultivation of chicken embryo. Dev Biol. 1974;41:391-394.
19. Wilting J, Christ B, Bokeloh M. A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Anat Embryol. 1991;183:259-271.
20. Wilson RF, Johnson MR, Marcus ML, Aylward PE, Skorton DJ, Collins S, White CW. The effect of coronary angioplasty on coronary flow reserve. Circulation. 1988;77:873-885.
21. Savchenko AP, Pomerantsev EV, Abugov SA, Blank ML. A videodensometric analysis of the characteristics of coronary blood flow using computed digital angiography in patients with ischemic heart disease. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1988;11:96-102.
22. Pijls NH, Bos HS, Uijen GJ, Van der Werf T. Is nonionic istonic iohexol the contrast agent of choice for quantitative myocardial vidodensitometry? Int J Card Imaging. 1988;3:117-126.
23. Chang BL, Drury, JK, Meerbaum S, Fishbein MC, Whiting JS, Corday E. Enhanced myocardial washout and retrograde blood delivery with synchronized retroperfusion during acute myocardial ischemia. J Am Coll Cardiol. 1987;9:1091-1098.
24. Nishimura RA, Rogers PJ, Holmes DR JR, Gehring DG, Bove AA. Assessment of myocardial perfusion by videodensitometry in the canine model. J Am Coll Cardiol. 1987;9:891-897.
25. Schlaudraff K, von Specht BU, Kolvenbach H, Stregmann T, Schumacher B. Induktion neuer funktioneller Blutgefasse beim Menschen. Langenhecks Arch Chir Chirurgisches Forum. 1994;164-172.
26. Albes JM, Kletzner T, Kotzerke J, Thiedemann KU, Schäfers HJ, Borst HG. Improvement of tracheal autograft revascularisation by means of fibroblast growth factor. Ann Thorac Surg. 1994;57:444-449.
27. Klagsbrun M, Shing Y. Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors Proc Natl Acad Sci U S A. 1985;82:805-809.
28. Rosengart TK, Johnson WV, Friesel RE, Clark R, Maciag T. Heparin protects heparin-binding growth factor-1 from proteolytic inactivation in vitro. Biochem Biophys Res Comm. 1988;152:432-440.
29. Ware A, Simons M. Angiogenesis in ischemic heart disease. Nat Med. 1997;3:158-164.